CLGN
CollPlant Biotechnologies Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$3.56
−1.79%Oct 9, 2026, 13:00 UTC
CollPlant Biotechnologies Ltd entered definitive agreements to issue and sell 989,301 ordinary shares or equivalents and warrants to purchase up to 1,483,952 shares in a private placement at a combined price of $3.74 per share and accompanying warrants.
Source:Oct 6, 2026, 11:00 UTC
LightSolver, a subsidiary of CollPlant Biotechnologies, filed a U.S. provisional patent application with the USPTO expanding its all-optical, laser-based photonic computing platform to advanced scientific and engineering simulations.
Source:Sep 30, 2026, 21:20 UTC
CollPlant Biotechnologies reported its financial results for the second quarter of 2026.
Source:Sep 22, 2026, 11:30 UTC
CollPlant Biotechnologies regained compliance with Nasdaq's minimum bid price continued listing requirement under Listing Rule 5550(a)(2).
Source:Sep 10, 2026, 11:00 UTC
CollPlant Biotechnologies will host an investor webinar on September 17, 2026 to present LightSolver.
Source:Aug 31, 2026, 12:00 UTC
CollPlant is acquiring LightSolver, entering the supercomputing and photonic computing markets.
Jun 30, 2026, 12:00 UTC
CollPlant Biotechnologies entered into a definitive agreement for a private placement of ordinary shares and warrants to raise $2.6 million.
Source: